In gastric cancer studies, high fibulin-5 expression correlates with more aggressive clinicopathologic features, such as poor differentiation, lymph node metastasis, advanced TNM stage and worse clinical outcome24–27. The gene discussed is FBLN5; the disease is metastatic malignant neoplasm in the lymph nodes.